Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia (CAAD-VT): A Randomised Trial

NCT05524077 is registered in ClinicalTrials.gov with Western Sydney Local Health District as lead sponsor.

NCT NCT05524077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05524077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia (CAAD-VT): A Randomised Trial
Lead sponsor
Western Sydney Local Health District
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 8, 2020
Completion date
June 30, 2026
Enrollment
162 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmogenic left ventricular cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy 1, cardiomyopathy ischemic, cardiomyopathy, dilated, cardiomyopathy, familial, cardiomyopathy, hypertrophic, heart disease structural disorder, sarcoidosis, ventricular tachycardia